Illumigene Pertusis Dna Amplification Assay, Illumigene Pertussis External Control Kit, Illumipro-10 Automated Isotherma
Bordetella Pertussis Dna Assay System. 510(k) K133673, from Meridian Bioscience, Inc. (Cincinnati, OH). Product code OZZ, class 2.
As of Nov 20, 2026, K133673 is an FDA 510(k) held by Meridian Bioscience, Inc., substantially equivalent on Mar 25, 2014 after 116 days, with no recalls tied to it in FDA's recall database.
- Review time: 116 days
- Recalls: 0
- Cited as a predicate by: 3 devices
The illumigene ® Pertussis DNA Amplification Assay, performed on the illumipro-10 ™, is a qualitative in vitro diagnostic test for the direct detection of Bordetella pertussis in human nasopharyngeal swab samples taken from patients suspected of having respiratory tract infection attributable to Bordetella pertussis.
- Filmarray Respiratory Panel (Rp)K123620 · Biofire Diagnostics, Inc. · Feb 11, 2013
- Filmarray RP PanelK120267 · Idaho Technology, Inc. · May 15, 2012
- Filmarray RP PanelK110764 · Idaho Technology, Inc. · Apr 27, 2011
- Filmarray Respiratory Panel (Rp)K103175 · Idaho Technology, Inc. · Feb 17, 2011
- Great Basin Bordetella Direct TestK170284 · Great Basin Scientific, Inc. · Mar 31, 2017
- ARIES Bordetella Assay; ARIES Bordetella Assay Protocol File KitK163626 · Luminex Corporation · May 2, 2017
- AmpliVue Bordetella AssayK143206 · Quidel Corporation · Dec 10, 2014
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Nov 29, 2013
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3980
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files